ALK Positive have launched an excellent Good Practice Guide from the patients perspective. The document aims to empower patients to be involved in and informed about their treatment. It is intended for use by patients diagnosed with Alk-Positive NonSmall Cell Lung Cancer (NSCLC), the majority of whom will have been diagnosed at Stage 4. It provides helpful questions to discuss diagnosis and treatment with healthcare professionals